Peer-reviewedCC BY 4.0Frontiers in Immunology7 Oct 2026

Myeloid-driven immunosuppression as a context-dependent therapeutic bottleneck in pancreatic ductal adenocarcinoma

Kai Sun^1,2
Lei Yang¹
Jingjing Li¹
Bo Jia¹
Min Fu¹
Qijia Zhang³
Wei Yang¹

¹Department of Hepatobiliary and Pancreatic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University
²School of Biomedical Engineering, Tsinghua University
³Department of Liver Intensive Care Unit, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University

HMGA2 Expression in Pancreatic Ductal Adenocarcinoma Controls Tumor Microenvironment and Immunosuppression via IL1α
N. Yamamoto, S. Dobersch, T. M. Robertson +20
bioRxiv2 Oct 2026PreprintAll rights reservedFull textOncologybioRxiv
Molecular mechanisms by which the intratumoral microbiome drives pancreatic ductal adenocarcinoma progression and therapeutic response
Zhonghua Qi, Miaolei Wang, Yajing Li +2
Frontiers in Immunology22 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyCrossref
CLDN18.2 in pancreatic ductal adenocarcinoma: Biomarker assessment, spatial heterogeneity and therapeutic modality selection
Ruyu Tan, Zhexin Zhang, Jiaxin Wang +3
Clinical and Translational Discovery26 Oct 2026Peer-reviewedCC BYFull textOncologyDOAJ
Decoding lipid metabolic reprogramming in pancreatic ductal adenocarcinoma: from tumor–microenvironment crosstalk to therapeutic resistance
Xingyu Liu, Zitong Ye, Liuyang Wang +9
Frontiers in Oncology26 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyCrossref
Disulfidptosis-related genes stratify molecular subtypes and highlight MYH9 as a prognostic biomarker and candidate therapeutic target in pancreatic ductal adenocarcinoma
Xiaoyan Fan, Ming Zhang, Dong Xu +4
Scientific Reports1 Jul 2026Peer-reviewedCC BYFull textOncologyDOAJ

Cite

BibTeX

@article{sun2026myeloiddriven,
  title = {{Myeloid-driven immunosuppression as a context-dependent therapeutic bottleneck in pancreatic ductal adenocarcinoma}},
  author = {Kai Sun and Lei Yang and Jingjing Li and Bo Jia and Min Fu and Qijia Zhang and Wei Yang},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1936958},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1936958/full},
  note = {CC BY 4.0},
}

RIS

TY  - JOUR
TI  - Myeloid-driven immunosuppression as a context-dependent therapeutic bottleneck in pancreatic ductal adenocarcinoma
AU  - Kai Sun
AU  - Lei Yang
AU  - Jingjing Li
AU  - Bo Jia
AU  - Min Fu
AU  - Qijia Zhang
AU  - Wei Yang
PY  - 2026
DA  - 2026/10/07
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1936958
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1936958/full
SN  - 1664-3224
ER  -

Related

Cite